A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer

Clinical trial NCT00087620 · TERMINATED

Trial details

NCT number

NCT00087620

Sponsor

Hoffmann-La Roche

Status

TERMINATED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2004-09-01

Primary completion

2004-10-01

View on ClinicalTrials.gov